| Code | Description | Claims | Beneficiaries | Total Paid |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
22,874 |
14,152 |
$1.03M |
| 80053 |
Comprehensive metabolic panel |
23,240 |
19,970 |
$549K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,148 |
5,407 |
$448K |
| 88307 |
|
2,208 |
1,864 |
$332K |
| 84443 |
Thyroid stimulating hormone (TSH) |
23,390 |
21,996 |
$318K |
| 88342 |
|
3,576 |
2,692 |
$269K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
8,369 |
7,858 |
$268K |
| 80050 |
General health panel |
2,572 |
2,381 |
$246K |
| 80061 |
Lipid panel |
14,016 |
12,980 |
$224K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
6,489 |
6,112 |
$187K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,703 |
1,537 |
$170K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,923 |
16,668 |
$147K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,486 |
3,206 |
$136K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,151 |
5,411 |
$132K |
| 36415 |
Collection of venous blood by venipuncture |
51,594 |
45,643 |
$124K |
| 82728 |
|
9,969 |
9,233 |
$123K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,803 |
7,557 |
$112K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,700 |
1,562 |
$94K |
| 83013 |
|
861 |
754 |
$88K |
| 82607 |
|
5,519 |
5,215 |
$86K |
| 86780 |
|
7,321 |
6,677 |
$83K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,122 |
9,071 |
$80K |
| 86803 |
|
6,002 |
5,604 |
$79K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,813 |
5,621 |
$78K |
| 83970 |
|
1,126 |
1,024 |
$66K |
| 88341 |
|
1,370 |
800 |
$66K |
| 86480 |
|
694 |
615 |
$63K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,399 |
1,278 |
$61K |
| 83550 |
|
8,555 |
7,905 |
$52K |
| 88304 |
|
2,791 |
2,313 |
$51K |
| 87077 |
|
4,910 |
4,163 |
$51K |
| 82784 |
|
3,563 |
3,125 |
$49K |
| 84702 |
|
3,345 |
2,426 |
$48K |
| 87186 |
|
4,581 |
4,126 |
$42K |
| 86481 |
|
281 |
265 |
$40K |
| 87150 |
|
1,384 |
1,217 |
$39K |
| 87340 |
|
4,822 |
4,420 |
$39K |
| 83540 |
|
8,841 |
8,175 |
$39K |
| 80076 |
|
1,688 |
1,412 |
$37K |
| 86850 |
|
3,128 |
2,757 |
$33K |
| 84165 |
|
2,897 |
2,304 |
$32K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,131 |
1,083 |
$31K |
| 86140 |
|
7,086 |
6,314 |
$31K |
| 84439 |
|
4,938 |
4,545 |
$29K |
| 84481 |
|
1,069 |
990 |
$28K |
| 82043 |
|
4,086 |
3,851 |
$27K |
| 80069 |
|
1,518 |
1,259 |
$27K |
| 87070 |
|
2,504 |
2,275 |
$27K |
| 82570 |
|
6,768 |
6,203 |
$25K |
| 83880 |
|
481 |
448 |
$25K |
| 86038 |
|
1,649 |
1,430 |
$21K |
| 84146 |
|
905 |
808 |
$21K |
| 83735 |
|
3,998 |
2,922 |
$20K |
| 87507 |
|
64 |
51 |
$20K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
137 |
135 |
$19K |
| 82746 |
|
854 |
792 |
$18K |
| 86160 |
|
633 |
559 |
$18K |
| 88108 |
|
756 |
557 |
$16K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
224 |
218 |
$16K |
| 86762 |
|
845 |
798 |
$15K |
| 85610 |
|
3,382 |
2,511 |
$15K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
195 |
179 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
529 |
411 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
76 |
69 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
224 |
215 |
$12K |
| 85027 |
|
2,138 |
1,886 |
$12K |
| 81001 |
|
3,293 |
2,921 |
$12K |
| 87210 |
|
1,874 |
1,718 |
$11K |
| 87522 |
Neg quan hep c or qual rna |
101 |
98 |
$11K |
| 88300 |
|
1,272 |
1,159 |
$10K |
| 84403 |
|
324 |
291 |
$10K |
| 88141 |
|
420 |
395 |
$9K |
| 80074 |
|
89 |
86 |
$8K |
| 86900 |
|
3,047 |
2,677 |
$7K |
| 86706 |
|
1,007 |
905 |
$7K |
| 87634 |
|
118 |
110 |
$7K |
| 82950 |
|
1,597 |
1,447 |
$7K |
| 86901 |
|
2,895 |
2,547 |
$7K |
| 83001 |
|
416 |
358 |
$7K |
| 84156 |
|
2,021 |
1,722 |
$6K |
| 84460 |
|
1,024 |
904 |
$6K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
178 |
172 |
$6K |
| 88312 |
|
100 |
77 |
$6K |
| 82077 |
|
52 |
41 |
$6K |
| 83615 |
|
1,328 |
1,043 |
$6K |
| 85652 |
|
2,818 |
2,538 |
$6K |
| 0240U |
|
45 |
42 |
$6K |
| 84153 |
|
346 |
327 |
$6K |
| 82565 |
|
959 |
823 |
$5K |
| 86431 |
|
733 |
674 |
$5K |
| 86334 |
|
334 |
265 |
$5K |
| 84100 |
|
1,273 |
856 |
$5K |
| 81025 |
|
603 |
538 |
$5K |
| 81003 |
|
2,057 |
1,837 |
$5K |
| 87088 |
|
764 |
689 |
$5K |
| G0124 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician |
146 |
144 |
$4K |
| 81015 |
|
1,423 |
1,307 |
$4K |
| 82550 |
|
645 |
548 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
71 |
70 |
$4K |
| 36416 |
|
792 |
660 |
$4K |
| 83690 |
|
779 |
688 |
$4K |
| 87205 |
|
1,079 |
957 |
$3K |
| 84703 |
|
277 |
245 |
$3K |
| 80177 |
|
239 |
209 |
$3K |
| 80164 |
|
244 |
211 |
$3K |
| 83516 |
|
141 |
100 |
$3K |
| 86704 |
|
286 |
269 |
$2K |
| 84550 |
|
749 |
596 |
$2K |
| 86592 |
|
560 |
541 |
$2K |
| 82274 |
|
83 |
82 |
$2K |
| 80081 |
|
25 |
24 |
$2K |
| 84450 |
|
562 |
517 |
$2K |
| 84484 |
|
211 |
193 |
$2K |
| 87529 |
|
41 |
29 |
$2K |
| 83002 |
|
120 |
96 |
$2K |
| 87631 |
|
14 |
14 |
$2K |
| 88302 |
|
118 |
90 |
$2K |
| 82670 |
|
75 |
68 |
$2K |
| 87040 |
|
107 |
92 |
$1K |
| 85046 |
|
376 |
303 |
$1K |
| 85246 |
|
58 |
52 |
$1K |
| 88311 |
|
255 |
215 |
$1K |
| 88313 |
|
60 |
36 |
$1K |
| 85245 |
|
45 |
39 |
$1K |
| 85240 |
|
56 |
50 |
$1K |
| 85730 |
|
251 |
224 |
$984.97 |
| 80178 |
|
137 |
125 |
$872.65 |
| 85018 |
|
484 |
424 |
$848.02 |
| 82947 |
|
218 |
185 |
$808.77 |
| 85379 |
|
102 |
76 |
$783.43 |
| G0141 |
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician |
34 |
33 |
$750.72 |
| 87493 |
|
24 |
24 |
$716.44 |
| 86696 |
|
13 |
12 |
$616.11 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
53 |
48 |
$587.87 |
| 82533 |
|
53 |
50 |
$582.49 |
| 80197 |
|
65 |
37 |
$571.18 |
| 82150 |
|
129 |
121 |
$514.29 |
| 82627 |
|
26 |
25 |
$513.30 |
| 86361 |
|
25 |
13 |
$511.88 |
| 85007 |
|
162 |
114 |
$496.09 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15 |
15 |
$351.16 |
| 84132 |
|
35 |
26 |
$316.22 |
| 88188 |
|
15 |
12 |
$260.32 |
| 83993 |
|
12 |
12 |
$215.93 |
| 82105 |
|
12 |
12 |
$197.35 |
| 82140 |
|
26 |
12 |
$145.70 |
| 86364 |
|
12 |
12 |
$110.69 |
| 86695 |
|
13 |
12 |
$65.95 |
| 82977 |
|
12 |
12 |
$54.89 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
145 |
143 |
$50.08 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
36 |
36 |
$38.61 |
| 90686 |
|
40 |
40 |
$27.72 |
| 86308 |
|
14 |
12 |
$23.94 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
25 |
25 |
$0.00 |